HA
Haw Par Corporation Limited
HAWPY · OTC
$53.50 +0.00% (+$0.00)
Market Cap $3.78B
P/E Ratio 14.46x
Div. Yield 2.34%
ROE 6.05%
Bulios Fair Price
$79.45
48.5% upside
Current Price
$53.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAWPY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair P/E 14.46x
P/FCF 14.26x
EV/EBITDA 41.94x
Growth
79 /100
Growing EPS growth 20.76%
Book val. growth 6.53%
Rev. growth 7.51%
Profitability
100 /100
Strong Gross margin 55.99%
FCF margin 117.05%
Net margin 115.44%
Quality
18 /100
Poor ROIC 1.44%
Asset turnover 0.05x
ROE 6.05%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -10.33x
Current ratio 7.13x
Stability
59 /100
Moderate Beta 0.17x
Profitable years 6
Rev. volatility 17.69%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAWPY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore